artificial intelligence has become an important role in the medical field. Machine learning
based on medical imaging
plays a significant complementary role in clinical decision-making. Moreover
the integration of imaging data with genomic information has introduced innovative avenues for genetic testing. The primary focus of this article was on the current state
limitations
and future trends of machine learning based on medical imaging for predicting epidermal growth factor receptor (
EGFR
) mutations in patients with non-small cell lung cancer (NSCLC).